FAKTOR-OPTIONSSCHEIN - NOVO-NORDISK B | Market Closed - Deutsche Boerse AG 03:46:49 2024-06-13 pm EDT | ||
| 0.015 EUR | +7.14% |
|
| 1 month | -25.00% | ||
| 3 months | -31.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 0.015 | +7.14% |
| 24-06-12 | 0.014 | -6.67% |
| 24-06-11 | 0.015 | +7.14% |
| 24-06-10 | 0.014 | 0.00% |
| 24-06-07 | 0.014 | -6.67% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 03:46 pm EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Société Générale
|
| WKN | SD5R8J |
| ISIN | DE000SD5R8J0 |
| Date issued | 2021-04-30 |
| Strike | 454.9 kr |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.09 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.1 € |
|---|---|
| Lowest since issue | 0.014 € |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
979.7
DKK
Average target price
929.5
DKK
Spread / Average Target
-5.13%
- Stock Market
- Certificates
- Certificat
